Cargando…

Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase

Tuberculosis (TB), the deadly disease caused by Mycobacterium tuberculosis (Mtb), kills more people worldwide than any other bacterial infectious disease. There has been a recent resurgence of TB drug discovery activities, resulting in the identification of a number of novel enzyme inhibitors. Many...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krah, Alexander, Grüber, Gerhard, Bond, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516385/ https://www.ncbi.nlm.nih.gov/pubmed/36186842 http://dx.doi.org/10.1016/j.crstbi.2022.09.001

Ejemplares similares

TBAJ-876 Retains Bedaquiline’s Activity against Subunits c and ε of Mycobacterium tuberculosis F-ATP Synthase
por: Sarathy, Jickky Palmae, et al.
Publicado: (2019)

TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug’s Uncoupler Activity
por: Sarathy, Jickky Palmae, et al.
Publicado: (2020)

Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase
por: Kundu, Subhashri, et al.
Publicado: (2016)

TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus
por: Sarathy, Jickky Palmae, et al.
Publicado: (2020)

Structure of the mycobacterial ATP synthase F(o) rotor ring in complex with the anti-TB drug bedaquiline
por: Preiss, Laura, et al.
Publicado: (2015)

Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876—A Less Toxic and More Potent Analogue of Bedaquiline
por: Choi, Peter J., et al.
Publicado: (2020)

Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis
por: Almeida, Deepak, et al.
Publicado: (2021)

Re-Understanding the Mechanisms of Action of the Anti-Mycobacterial Drug Bedaquiline
por: Sarathy, Jickky Palmae, et al.
Publicado: (2019)

Bedaquiline inhibits the yeast and human mitochondrial ATP synthases
por: Luo, Min, et al.
Publicado: (2020)

Targeting Mycobacterial F-ATP Synthase C-Terminal α Subunit Interaction Motif on Rotary Subunit γ
por: Harikishore, Amaravadhi, et al.
Publicado: (2021)

ATP binding by an F(1)F(o) ATP synthase ε subunit is pH dependent, suggesting a diversity of ε subunit functional regulation in bacteria
por: Krah, Alexander, et al.
Publicado: (2023)

Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis
por: Xu, Jian, et al.
Publicado: (2021)

Modelling of mycobacterial load reveals bedaquiline’s exposure–response relationship in patients with drug-resistant TB
por: Svensson, Elin M, et al.
Publicado: (2017)

Structures of mycobacterial ATP synthase bound to inhibitors
por: Courbon, Gautier M., et al.
Publicado: (2022)

Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration
por: Maloney, Sara E., et al.
Publicado: (2023)

Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase
por: Fiorillo, Marco, et al.
Publicado: (2021)

The structural basis of a high affinity ATP binding ε subunit from a bacterial ATP synthase
por: Krah, Alexander, et al.
Publicado: (2017)

Disrupting coupling within mycobacterial F-ATP synthases subunit ε causes dysregulated energy production and cell wall biosynthesis
por: Saw, Wuan-Geok, et al.
Publicado: (2019)

Neuroprotective Effect of a Novel ATP-Synthase Inhibitor Bedaquiline in Cerebral Ischemia-Reperfusion Injury
por: Umbrasas, Danielius, et al.
Publicado: (2021)

Bedaquiline for multidrug-resistant TB in paediatric patients
por: Moodliar, R., et al.
Publicado: (2021)

Effectiveness of the Novel Anti-TB Bedaquiline against Drug-Resistant TB in Africa: A Systematic Review of the Literature
por: Traoré, Afsatou Ndama, et al.
Publicado: (2022)

Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug
por: Svensson, Elin M., et al.
Publicado: (2015)

Crystallographic structure of the turbine C-ring from spinach chloroplast F-ATP synthase
por: Balakrishna, Asha Manikkoth, et al.
Publicado: (2014)

Single mutations in the ε subunit from thermophilic Bacillus PS3 generate a high binding affinity site for ATP
por: Krah, Alexander, et al.
Publicado: (2018)

Prolonged use of bedaquiline in the treatment for MDR-TB in a child
por: Gubkina, Marina F., et al.
Publicado: (2021)

Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
por: Kambili, C., et al.
Publicado: (2022)

Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase
por: Haagsma, Anna C., et al.
Publicado: (2011)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019)

Insights into the regulatory function of the ɛ subunit from bacterial F-type ATP synthases: a comparison of structural, biochemical and biophysical data
por: Krah, Alexander, et al.
Publicado: (2018)

Synergistic Li/Li Bimetallic System for the Asymmetric Synthesis of Antituberculosis Drug TBAJ-587
por: Ahmad, Tanveer, et al.
Publicado: (2023)

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022)

Empirical ways to identify novel Bedaquiline resistance mutations in AtpE
por: Karmakar, Malancha, et al.
Publicado: (2019)

Efficient ATP synthesis by thermophilic Bacillus F(o)F(1)-ATP synthase
por: Soga, Naoki, et al.
Publicado: (2011)

F-Type ATP Synthase Assembly Factors Atp11 and Atp12 in Arabidopsis
por: Duan, Zhikun, et al.
Publicado: (2020)

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
por: Oelofse, S., et al.
Publicado: (2021)

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline
por: Kaniga, K., et al.
Publicado: (2022)

Correction to: Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
Publicado: (2023)

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
por: Millard, James, et al.
Publicado: (2023)

Rotary catalysis of F(o)F(1)-ATP synthase
por: Watanabe, Rikiya
Publicado: (2013)

atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure
por: Le Ray, Laure Fournier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j7c0rtf852u230gi9qh5d5drfd